Schuind, Anne

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50 years of age: Results from a phase III, randomized, non-inferiority trial

Ofori-Anyinam, O., Leroux-Roels, G., Drame, M., Aerssens, A., Maes, C., Amanullah, A., Schuind, A., Li, P., Jain, V. K., & Innis, B. L. (2017) · Vaccine

Influenza Virus Research StudiesPneumonia and Respiratory Infections

Cited by 31

Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study

Kim, J. H., Drame, M., Puthanakit, T., Chiu, N.-C., Supparatpinyo, K., Huang, L.-M., Chiu, C.-H., Chen, P.-Y., Hwang, K.-P., Danier, J., et al. (2021) · Pediatric Infectious Disease Journal

Influenza Virus Research StudiesBacterial Infections and Vaccines

Cited by 14